Morningside Venture Investments Ltd, 10% Owner at Apnimed, Inc. (APMD), bought 312,500 shares at $16.00 ($5.0M) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Morningside Venture Investments Ltd purchased $5M of APMD stock at $16.00, marking the largest insider purchase in the company's history and a significant vote of confidence from a major shareholder. This rare reversal comes as the stock sits near its 52-week low, suggesting the market may be overlooking the company's recent index inclusion.
The stock is currently trading at $26.39, down 7.34% from its 52-week high of $28.48, but remains 62.6% above its 52-week low of $16.23. The recent addition to the NASDAQ Composite Index on August 14 provides a specific catalyst for visibility and liquidity.
The stock is currently trading 62.6% above its 52-week low, meaning there is limited room for further downside recovery if the company fails to execute on its growth strategy.
Nothing distinguishes this filing.
| Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |
| AMLX | SELL | 2023-03-16 | $14.9M | — | Filing → |